These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11983636)

  • 1. Genetic and host factors for dementia in Down's syndrome.
    Schupf N; Sergievsky GH
    Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome.
    Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R
    Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
    Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
    Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome.
    Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N
    Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of dementia is associated with age at menopause in women with Down's syndrome.
    Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
    Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at onset of dementia and age of menopause in women with Down's syndrome.
    Cosgrave MP; Tyrrell J; McCarron M; Gill M; Lawlor BA
    J Intellect Disabil Res; 1999 Dec; 43 ( Pt 6)():461-5. PubMed ID: 10622361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
    Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 12. Down's syndrome and Alzheimer's disease: towards secondary prevention.
    Ness S; Rafii M; Aisen P; Krams M; Silverman W; Manji H
    Nat Rev Drug Discov; 2012 Sep; 11(9):655-6. PubMed ID: 22935789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype.
    Mann DM; Pickering-Brown SM; Siddons MA; Iwatsubo T; Ihara Y; Asami-Odaka A; Suzuki N
    Neurosci Lett; 1995 Aug; 196(1-2):105-8. PubMed ID: 7501233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
    Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of apolipoprotein E on dementia in persons with Down's syndrome.
    Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Arias-Vasquez A; Sayed-Tabatabaei FA; Vergeer-Drop J; Eikelenboom P; van Gool WA; van Duijn CM
    Neurobiol Aging; 2008 Jun; 29(6):828-35. PubMed ID: 17250929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer's disease and Down's syndrome: treating two paths to dementia.
    Weksler ME; Szabo P; Relkin NR; Reidenberg MM; Weksler BB; Coppus AM
    Autoimmun Rev; 2013 Apr; 12(6):670-3. PubMed ID: 23201920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The apolipoprotein E genotype and Down's syndrome].
    Rascón Trincado MV; González Sarmiento R; Salazar A-Villalobos V
    Rev Clin Esp; 1997 Oct; 197(10):680-3. PubMed ID: 9424665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.